Can a Two-Pronged antibody boost chemo against Hard-to-Treat colorectal cancer?
Disease control
Recruiting now
This phase II trial is testing whether adding an experimental drug called PM8002 (pumitamig) to standard chemotherapy can shrink tumors in people with a common type of metastatic colorectal cancer that has not been treated before. PM8002 is a bispecific antibody designed to block…
Phase: PHASE2 • Sponsor: Biotheus Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC